The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate

BACKGROUND AND AIMS: Immunotherapy with immune checkpoint inhibitors (ICIs) is a pillar of many advanced tumors. However, there is scarce data concerning the rate of viral hepatitis screening in this population or the risk of viral reactivation. METHODS: Retrospective–prospective study that includes...

Descripción completa

Detalles Bibliográficos
Autores principales: Aceituno, Laia, Bañares, Juan, Ruiz-Ortega, Lourdes, Callejo-Pérez, Ana, Muñoz-Couselo, Eva, Ortiz-Velez, Carolina, Díaz-Mejía, Nely, Barreira-Díaz, Ana, Carreras, María José, Farriols, Anna, Buti, María, Riveiro-Barciela, Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335294/
https://www.ncbi.nlm.nih.gov/pubmed/35911389
http://dx.doi.org/10.3389/fmed.2022.916213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335294/
https://www.ncbi.nlm.nih.gov/pubmed/35911389
http://dx.doi.org/10.3389/fmed.2022.916213

Ejemplares similares